Profile of:
Wilson Bautista-Molano
Wilson Bautista-Molano MD, PhD is Professor of Medicine, Researcher and Consultant Rheumatologist and is the Head of Rheumatology Department leading the Spondylarthritis Clinical Care Center at University Hospital Fundación Santa Fe de Bogotá in Colombia. He is University Professor in the School of Medicine at Universidad El Bosque and Universidad de los Andes. He is currently a member of the Board of Directors of the Colombian Association of Rheumatology. He is skilled in Clinical Research, Autoimmune Diseases, Epidemiology, Immunology and Outcome Assessment of Musculoskeletal conditions. He has strong business development professional with a Doctor of Philosophy (PhD) and Doctor of Medicine (MD). He also has strong leadership focused to transdisciplinary teamwork with excellent interpersonal relationship management. He has also designed and led several multicenter international studies and epidemiological cohorts aimed at evaluating diagnosis, imaging and disease manifestations of rheumatic conditions. He is a decisive leader, advisor and keynote speaker with a proven ability to develop and manage research and educational projects in Biomedical Science and Immuno-mediated diseases. Currently, he served as Chair of the Study Group of Axial Spondylarthritis and Psoriatic Arthritis of PANLAR (PanAmerican League of Associations for Rheumatology) leading continental initiatives in the field of Spondyloarthritis including the registry ESPALDA. He is also international member of GRAPPA group. Their published Research and Teaching activities are focused on Musculoskeletal and Inflammatory Diseases with mechanisms of Autoimmunity including Axial Spondylarthritis and Psoriatic Arthritis.
Full name: Wilson Bautista-Molano
Current country: Colombia
Membership level: Full
Type of membership: Member
Number of publications: 34
Burden of Disease in Psoriatic Arthritis in Latin America: a Systematic Literature Review (2024)
https://pubmed.ncbi.nlm.nih.gov/38114817/
Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations (2023)
https://pubmed.ncbi.nlm.nih.gov/36243409/
Implementation of screening criteria for inflammatory bowel disease in patients with spondyloarthritis and its association with disease and endoscopic activity (2023)
https://pubmed.ncbi.nlm.nih.gov/36053473/
Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries (2023)
https://pubmed.ncbi.nlm.nih.gov/36787993/
Expanding the Assessment of Overall Functioning and Health Status in Patients With Spondyloarthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/37061227/
Instrument selection for the ASAS core outcome set for axial spondyloarthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/35680390/
Differential gut microbiome in spondyloarthritis patients associated to Blastocystis colonization (2023)
https://pubmed.ncbi.nlm.nih.gov/37596338/
Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis (2023)
https://pubmed.ncbi.nlm.nih.gov/37803079/
Time to address the challenge of difficult to treat psoriatic arthritis: results from an international survey (2023)
https://pubmed.ncbi.nlm.nih.gov/37963707/
Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/34534275/
Decreased fecal calprotectin levels in Spondyloarthritis patients colonized by Blastocystis spp (2022)
https://pubmed.ncbi.nlm.nih.gov/36151228/
Oral manifestations associated with inflammatory bowel disease and early endoscopic findings in patients with spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/36348398/
Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/33462157/
Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/33419481/
The ASAS-OMERACT core domain set for axial spondyloarthritis. (2021)
https://pubmed.ncbi.nlm.nih.gov/34489113/
Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial Spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34534275/
Frequency and distribution of Blastocystis sp. subtypes in patients with spondyloarthritis in Bogotá, Colombia (2021)
https://pubmed.ncbi.nlm.nih.gov/34667886/
HLA-B Allele, Genotype, and Haplotype Frequencies in a Group of Healthy Individuals in Colombia (2021)
https://pubmed.ncbi.nlm.nih.gov/33790206/
Increasing of SIgA serum levels may reflect subclinical intestinal involvement in non-radiographic axial and peripheral spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/32876782/
Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/34750246/
Treatment of Psoriatic Arthritis: Challenges in Latin America (2021)
https://pubmed.ncbi.nlm.nih.gov/33888411/
Adipokines and periodontal markers as risk indicators of early rheumatoid arthritis: a cross-sectional study. (2021)
https://pubmed.ncbi.nlm.nih.gov/32740810/
Design of an algorithm for the diagnostic approach of patients with joint pain (2021)
https://pubmed.ncbi.nlm.nih.gov/32840702/
Treatment of Psoriatic Arthritis: Challenges in Latin America (2021)
https://pubmed.ncbi.nlm.nih.gov/33888411/
Increasing of SIgA serum levels may reflect subclinical intestinal involvement in non-radiographic axial and peripheral spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/32876782/
Frequency and distribution of Blastocystis sp. subtypes in patients with spondyloarthritis in Bogotá, Colombia (2021)
https://pubmed.ncbi.nlm.nih.gov/34667886/
Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/34750246/
2021 clinical practice guideline for the early detection, diagnosis, treatment, and monitoring of patients with axial spondyloarthritis. Colombian Association of Rheumatology (2021)
https://pubmed.ncbi.nlm.nih.gov/35305953/
2021 clinical practice guidelines for the diagnosis, treatment, and follow-up of patients with peripheral spondyloarthritis. Colombian Association of Rheumatology (2021)
https://pubmed.ncbi.nlm.nih.gov/35033487/
Assessment of SpondyloArthritis International Society (ASAS) Consensus on Spanish Nomenclature for Spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/30193774/
Levels of satisfaction with rheumatoid arthritis treatment and associated alignment between physicians and patients across Latin America (2020)
https://pubmed.ncbi.nlm.nih.gov/32030635/
Physician-patient alignment in satisfaction with psoriatic arthritis treatment in Latin America (2020)
https://pubmed.ncbi.nlm.nih.gov/31993888/
International league of associations for rheumatology recommendations for the management of psoriatic arthritis in resource-poor settings (2020)
https://pubmed.ncbi.nlm.nih.gov/31950441/
Treatment of uveitis and ankylosing spondylitis refractory to three tumor necrosis factor alpha inhibitors drugs with golimumab (2020)
https://pubmed.ncbi.nlm.nih.gov/29472171/
